CD8A and neoplasm: The elevated tumor rejection by ATXN3 suppression was largely diminished by CD8+ T cell depletion (Supplemental Figure 8A), confirming our initial conclusion that tumoral ATXN3 achieves its immune surveillance function in part through suppressing, either directly or indirectly, CD8+ T cell antitumor immunity.